Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-13

FDA Approved: MOXIFLOXACIN OPHTHALMIC SOLUTION — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals' original application for MOXIFLOXACIN OPHTHALMIC SOLUTION, a generic ophthalmic antibiotic, for the treatment of bacterial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Moxifloxacin ophthalmic solution (moxifloxacin)

Snippet

ORIG AP for MOXIFLOXACIN OPHTHALMIC SOLUTION (MOXIFLOXACIN OPHTHALMIC SOLUTION)